pediatrics, intestinal adaptation, short bowel syndrome, Intestinal failurepediatría, adaptación intestinal,, síndrome de intestino corto, insuficiencia intestinal

1. Modi BP, Galloway DP, Gura K, Nucci A, Plogsted S, Tucker A, et al. ASPEN definitions in pediatric intestinal failure. J Parenter Enteral Nutr. 2022 Jan 1;46(1):42-59. https://doi.org/10.1002/jpen.2232
2. Duggan CP, Jaksic T. Pediatric intestinal failure. N Engl J Med. 2017;377(7):666-75. https://doi.org/10.1056/NEJMra1602650
3. Mezoff EA, Cole CR, Cohran VC. Etiology and medical management of pediatric intestinal failure. Gastroenterol Clin North Am. 2019;48(4):483-98. https://doi.org/10.1016/j.gtc.2019.08.003
4. Stanger JD, Oliveira C, Blackmore C, Avitzur Y, Wales PW. The impact of multi-disciplinary intestinal rehabilitation programs on the outcome of pediatric patients with intestinal failure: a systematic review and meta-analysis. J Pediatr Surg. 2013 May;48(5):983-92. https://doi.org/10.1016/j.jpedsurg.2013.02.070
5. Ministerio de Salud y Protección Social. Resolución 5265 de 2018. Listado de enfermedades huérfanas [internet]. Disponible en: http://achc.org.co/wp-content/uploads/2018/12/RESOLUCIÓN-No.-5265-DE-2018-MINSALUD-LISTADO-ENFERMEDADES-HUÉRFANAS..pdf
6. Contreras-Ramírez MM, Giraldo-Villa A, Henao-Roldan C, Martínez-Volkmar MI, Valencia-Quintero AF, Montoya-Delgado DC, et al. Evolución en niños con falla intestinal en un hospital de referencia en Medellín, Colombia. Rev Gastroenterol Mex. 2016;81(1):21-7. https://doi.org/10.1016/j.rgmx.2015.12.002
7. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med. 2011;364.
8. Squires RH, Duggan C, Teitelbaum DH, Wales PW, Balint J, Venick R, et al. Natural history of pediatric intestinal failure: initial report from the pediatric intestinal failure consortium. J Pediatr. 2012;161(4):723-8. https://doi.org/10.1016/j.jpeds.2012.03.062
9. King A. Intestinal atresia. UpToDate [internet]. 2024 abr 25. Disponible en: https://www.uptodate.com/contents/intestinal-atresia
10. Kleinman R, Goulet OJ, Mieli-Vergani G, Sanderson I, Sherman P, Shneider B. Walker’s pediatric gastrointestinal disease. 6.ª ed. Pmph USA; 2018.
11. Christison-Lagay ER, Kelleher CM, Langer JC. Neonatal abdominal wall defects. Semin Fetal Neonatal Med. 2011 Jun;16(3):164-72. https://doi.org/10.1016/j.siny.2011.02.003
12. Jones AM, Isenburg J, Salemi JL, Arnold KE, Mai CT, Aggarwal D, et al. Increasing prevalence of gastroschisis — 14 states, 1995-2012. MMWR Morb Mortal Wkly Rep. 2016 Jan 22;65(2):23-6.
13. Melo dos Santos AL, Wander Almeida Braga R, Bender Kohnert Seidler H, Pinheiro de Abreu Miranda R, Itália Teixeira Salvador I, de Carvalho E. Pediatric intestinal pseudo-obstruction: role of histopathology. J Pediatr Surg Case Rep. 2020;57:101449. https://doi.org/10.1016/j.epsc.2020.101449
14. Thapar N, Saliakellis E, Benninga MA, Borrelli O, Curry J, Faure C, et al. Paediatric intestinal pseudo-obstruction: evidence and consensus-based recommendations from an ESPGHAN-Led Expert Group. J Pediatr Gastroenterol Nutr. 2018 Jun 1;66(6):991-1019.
15. Ruemmele FM, Schmitz J, Goulet O. Microvillous inclusion disease (microvillous atrophy). Orphanet J Rare Dis. 2006 Jun 26;1:22. https://doi.org/10.1186/1750-1172-1-22
16. Das B, Sivagnanam M. Congenital tufting enteropathy: biology, pathogenesis and mechanisms. J Clin Med. 2021;10(1):1-12.
17. Kelly DA. Intestinal failure-associated liver disease: what do we know today? En: Gastroenterology. Filadelfia: W. B. Saunders; 2006.
18. Rosete BE, Wendel D, Horslen SP. Teduglutide for pediatric short bowel syndrome patients. Expert Rev Gastroenterol Hepatol. 2021;15(7):727-33. https://doi.org/10.1080/17474124.2021.1913052
19. Cernat E, Corlett C, Iglesias N, Onyeador N, Steele J, Batra A. Short bowel syndrome in infancy: recent advances and practical management. Frontline Gastroenterol. 2020;614-21. https://doi.org/10.1136/flgastro-2020-101457
20. Lapillonne A, Fidler Mis N, Goulet O, van den Akker CHP, Wu J, Koletzko B, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Lipids. Clin Nutr. 2018;37(6):2324-36. https://doi.org/10.1016/j.clnu.2018.06.946
21. Mesotten D, Joosten K, van Kempen A, Verbruggen S, Braegger C, Bronsky J, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: carbohydrates. Clin Nutr. 2018;37(6):2337-43. https://doi.org/10.1016/j.clnu.2018.06.947
22. van Goudoever JB, Carnielli V, Darmaun D, Sainz de Pipaon M, Braegger C, Bronsky J, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: amino acids. Clin Nutr. 2018;37(6):2315-23. https://doi.org/10.1016/j.clnu.2018.06.945
23. Protheroe S. Long-term parenteral nutrition. Paediatrics and child health (United Kingdom). 2019;29(9):369-76. https://doi.org/10.1016/j.paed.2019.06.001
24. Wiskin AE, Russell R, Barclay AR, Thomas J, Batra A. Prevalence of home parenteral nutrition in children. Clin Nutr ESPEN. 2021 Apr 1;42:138-41. https://doi.org/10.1016/j.clnesp.2020.12.029
25. Spencer AU, Kovacevich D, McKinney-Barnett M, Hair D, Canham J, Maksym C, et al. Pediatric short-bowel syndrome: the cost of comprehensive care. Am J Clin Nutr. 2008;88(6):1552-9. https://doi.org/10.3945/ajcn.2008.26007
26. Puntis JWL, Hojsak I, Ksiazyk J, Braegger C, Bronsky J, Cai W, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Organisational aspects. Clin Nutr. 2018 Dec 1;37(6 Pt B):2392-400. https://doi.org/10.1016/j.clnu.2018.06.953
27. Lacaille F, Gupte G, Colomb V, D’antiga L, Hartman C, Hojsak I, et al. Intestinal failure-associated liver disease: a position paper of the ESPGHAN working group of intestinal failure and intestinal transplantation. J Pediatr Gastroenterol Nutr. 2015 Feb 6;60(2):272-83. https://doi.org/10.1097/MPG.0000000000000586
28. Navaratnarajah N, Girard G, Sant’Anna G, Langlois H, Sant’Anna AM. The impact of a lipid injectable emulsion (SMOF) on conjugated bilirubin levels in children receiving prolonged parenteral nutrition: a large single center experience. Clin Nutr ESPEN. 2022 Jun 1;49:289-94. https://doi.org/10.1016/j.clnesp.2022.03.036
29. Andorsky DJ, Lund DP, Lillehei CW, Jaksic T, DiCanzio J, Richardson DS, et al. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr. 2001;139(1):27-33.
30. Premkumar MH, Soraisham A, Bagga N, Massieu LA, Maheshwari A. Nutritional management of short bowel syndrome. Clin Perinatol. 2022;49(2):557-72.
31. Goulet O, Olieman J, Ksiazyk J, Spolidoro J, Tibboe D, Köhler H, et al. Neonatal short bowel syndrome as a model of intestinal failure: physiological background for enteral feeding. Clin Nutr. 2013;32(2):162-71. https://doi.org/10.1016/j.clnu.2012.09.007
32. Kocoshis SA, Merritt RJ, Hill S, Protheroe S, Carter BA, Horslen S, et al. Safety and efficacy of teduglutide in pediatric patients with intestinal failure due to short bowel syndrome: a 24-week, phase III study. J Parenter Enteral Nutr. 2020;44(4):621-31. https://doi.org/10.1002/jpen.1690
33. Registro Invima. Revestive® 5 mg invima 2020MBT-0019573 [internet]. Disponible en: https://consultaregistro.invima.gov.co/Consultas/consultas/consreg_encabcum.jsp
34. Wales P, Nasr A, De Silva N, Yamada J. Human growth hormone and glutamine for patients with short bowel syndrome. Cochrane Database Syst Rev. 2010 Jun 16;(6):CD006321. https://doi.org/10.1002/14651858.CD006321.pub2
35. Cheung GWC, Kokorovic A, Lam CKL, Chari M, Lam TKT. Intestinal cholecystokinin controls glucose production through a neuronal network. Cell Metab. 2009 Aug 6;10(2):99-109.
36. Chandra R, Liddle RA. Cholecystokinin. Curr Opin Endocrinol Diabetes Obes. 2007 Feb;14(1):63-7. https://doi.org/10.1097/MED.0b013e3280122850
37. Tsai S, Strouse PJ, Drongowski RA, Islam S, Teitelbaum DH. Failure of cholecystokinin-octapeptide to prevent TPN-associated gallstone disease. J Pediatr Surg. 2005;40(1):263-7.
38. McMellen ME, Wakeman D, Longshore SW, McDuffie LA, Warner BW. Growth factors: possible roles for clinical management of the short bowel syndrome. Semin Pediatr Surg. 2010 Feb;19(1):35-43. https://doi.org/10.1053/j.sempedsurg.2009.11.010
39. Sigalet DL, Martin GR, Butzner JD, Buret A, Meddings JB. A pilot study of the use of epidermal growth factor in pediatric short bowel syndrome. J Pediatr Surg. 2005 May;40(5):763-8. https://doi.org/10.1016/j.jpedsurg.2005.01.038
40. Canul-Medina G, Coop-Gamas O, Guevara-Guarfias U, Montaño-Candia MT, Machado-Villarroel L, Montaño-Candia M, Zúñiga-Rivera A. Glutamina en nutrición clínica. Rev Endocrinol Nutr. 2010;17(4):161-9.
41. Josyabhatla R, Imseis EM. Pediatric intestinal failure and the microbiome. Semin Perinatol. 2021;45(6):151453. https://doi.org/10.1016/j.semperi.2021.151453
42. Ladd AP, Grosfeld JL, Pescovitz OH, Johnson NB. The effect of growth hormone supplementation on late nutritional independence in pediatric patients with short bowel syndrome. J Pediatr Surg. 2005;40(2):442-5. https://doi.org/10.1016/j.jpedsurg.2004.10.011
43. Jones BA, Hull MA, Potanos KM, Zurakowski D, Fitzgibbons SC, Ching YA, et al. Report of 111 consecutive patients enrolled in the international serial transverse enteroplasty (STEP) data registry: a retrospective observational study. J Am Coll Surg. 2013;216(3):438-46. https://doi.org/10.1016/j.jamcollsurg.2012.12.018
44. Martínez Rivera A, Wales PW. Intestinal transplantation in children: current status. Pediatr Surg Int. 2016 Jun;32(6):529-40. https://doi.org/10.1007/s00383-016-3885-2
45. Smith JM, Skeans MA, Horslen SP, Edwards EB, Harper AM, Snyder JJ, et al. OPTN/SRTR 2015 Annual Data Report: intestine. Am J Transplant. 2017 Jan;17 Suppl 1:252-285. https://doi.org/10.1111/ajt.14127
46. Gondolesi GE, Rumbo C, Fernández A, Mauriño E, Ruf A. Trasplante intestinal. revisión y descripción de su evolución en Latinoamérica. Acta Gastroenterol Latinoam. 2009;39(1):63-80.
47. Khalaf RT, Sokol RJ. New Insights into intestinal failure-associated liver disease in children. Hepatology. 2020;71(4):1486-98.
48. Norsa L, Mutanen A, Sharkey L, Spagnuolo MI. IFALD in children: what’s new? A narrative review.
49. Hartman C, Shamir R, Simchowitz V, Lohner S, Cai W, Decsi T, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Complications. Clin Nutr. 2018 Dec;37(6 Pt B):2418-29. https://doi.org/10.1016/j.clnu.2018.06.956
50. Rahhal R, Abu-El-Haija MA, Fei L, Ebach D, Orkin S, Kiscaden E, et al. Systematic review and meta-analysis of the utilization of ethanol locks in pediatric patients with intestinal failure. J Parenter Enteral Nutr. 2018;42(4):690-701.
51. Belza C, Wales PW. Management of pediatric intestinal failure related to short bowel syndrome. Semin Pediatr Surg. 2022;31(3):151175. https://doi.org/10.1016/j.sempedsurg.2022.151175
52. Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical guideline: small intestinal bacterial overgrowth. Am J Gastroenterol. 2020;115(2):165-78.
53. Cole CR, Frem JC, Schmotzer B, Gewirtz AT, Meddings JB, Gold BD, et al. The rate of bloodstream infection is high in infants with short bowel syndrome: relationship with small bowel bacterial overgrowth, enteral feeding, and inflammatory and immune responses. J Pediatr. 2010;156(6):941-7.e1. https://doi.org/10.1016/j.jpeds.2009.12.008
54. Hong CR, Han SM, Staffa SJ, Carey AN, Modi BP, Jaksic T. Long-term outcomes of ultrashort bowel syndrome due to malrotation with midgut volvulus managed at an interdisciplinary pediatric intestinal rehabilitation center. J Pediatr Surg. 2019;54(5):964-7. https://doi.org/10.1016/j.jpedsurg.2019.01.025
55. Hess RA, Welch KB, Brown PI, Teitelbaum DH. Survival outcomes of pediatric intestinal failure patients: analysis of factors contributing to improved survival over the past two decades. J Surg Res. 2011;170(1):27-31. https://doi.org/10.1016/j.jss.2011.03.037
56. Merritt RJ, Cohran V, Raphael BP, Sentongo T, Volpert D, Warner BW, et al. Intestinal rehabilitation programs in the management of pediatric intestinal failure and short bowel syndrome. J Pediatr Gastroenterol Nutr. 2017;65(5):588-96. https://doi.org/10.1097/MPG.0000000000001722

Vol. 64 Núm. 3 (2023)